Nutex Health Non Currrent Assets Other Over Time
| NUTX Stock | USD 32.91 1.02 3.20% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Nutex Health Performance and Nutex Health Correlation. Nutex |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nutex Health. If investors know Nutex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nutex Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.18) | Revenue Per Share 60.2 | Quarterly Revenue Growth 0.256 | Return On Assets 0.0376 | Return On Equity (0.35) |
The market value of Nutex Health is measured differently than its book value, which is the value of Nutex that is recorded on the company's balance sheet. Investors also form their own opinion of Nutex Health's value that differs from its market value or its book value, called intrinsic value, which is Nutex Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nutex Health's market value can be influenced by many factors that don't directly affect Nutex Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nutex Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nutex Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nutex Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Currrent Assets Other Analysis
Compare Nutex Health and related stocks such as FOXO Technologies, Heartbeam, and EUDA Health Holdings Non Currrent Assets Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FOXO | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 2.7 M | 21.1 M | 114 K | 108.3 K |
| BEAT | 599.7 K | 1.4 M | 627 K | 731 K | 1.3 M | 1.7 M | 2.4 M | 2.8 M | 3.3 M | 17.5 M | 50 K | 50 K | 50 K | 57.5 K | 54.6 K |
| EUDA | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.4 M) | (124.5 K) | 380.1 K | 399.1 K |
| PRVA | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 4.5 M | 4.5 M | 4.7 M | 8.6 M | 5.1 M |
| EVH | (6 M) | (6 M) | (6 M) | 5.8 M | (647 K) | 1.6 M | 6 M | 3.3 M | 6.1 M | 8.3 M | 7.3 M | 13 M | 32.3 M | 33 M | 34.7 M |
| HSTM | 600 K | 2.9 M | 581 K | 739 K | 3.8 M | 4.6 M | 3.9 M | 4.5 M | 17.3 M | 18.5 M | 21.7 M | 25 M | 29.2 M | 32.4 M | 34 M |
| STRM | 100 K | 367.5 K | 383.7 K | 500.6 K | 823.7 K | 1 M | 671.7 K | 642.2 K | 681 K | 695 K | 886 K | 948 K | 1.7 M | 1.7 M | 1.2 M |
| NRC | 100 K | 7.2 M | 5.9 M | 5 M | 5.7 M | 4.1 M | 3.9 M | 4.7 M | 7.6 M | 10.1 M | 10.3 M | 9.8 M | 7.9 M | 4.7 M | 4.5 M |
| LIFW | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | (230 M) | 3.1 B | 3.1 B | 3.6 B | 3.8 B |
| HCTI | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | (3 M) | (3 M) | (3 M) | (2.6 M) | 816.2 K | (11.9 M) | 304 K | 319.2 K |
| BFRG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| MGRX | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K | 15.2 K | 13.6 K |
Nutex Health and related stocks such as FOXO Technologies, Heartbeam, and EUDA Health Holdings Non Currrent Assets Other description
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.My Equities
My Current Equities and Potential Positions
| Nutex Health | NUTX |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Florida; U.S.A |
| Exchange | NASDAQ Exchange |
USD 32.91
Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.